|
SLC12A6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.764240E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.604000E-01 |
| Normal-vs-Stage2 |
4.811700E-02 |
| Normal-vs-Stage3 |
4.0199000000074E-05 |
| Normal-vs-Stage4 |
1.61101999999191E-05 |
| Stage1-vs-Stage2 |
1.014830E-01 |
| Stage1-vs-Stage3 |
2.87080000005435E-06 |
| Stage1-vs-Stage4 |
4.74340000000684E-06 |
| Stage2-vs-Stage3 |
1.323570E-01 |
| Stage2-vs-Stage4 |
4.177800E-02 |
| Stage3-vs-Stage4 |
3.596000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.035900E-02 |
| Normal-vs-AfricanAmerican |
1.643800E-02 |
| Normal-vs-Asian |
2.916400E-01 |
| Caucasian-vs-AfricanAmerican |
5.967000E-01 |
| Caucasian-vs-Asian |
7.809600E-02 |
| AfricanAmerican-vs-Asian |
3.419700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.243700E-04 |
| Normal-vs-Female |
4.912600E-01 |
| Male-vs-Female |
8.364700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.058100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.485400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.846400E-04 |
| Normal-vs-Age(81-100Yrs) |
7.643700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.445400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.662200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.054600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.519240E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.993200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.087200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.814100E-02 |
| Normal-vs-Grade 2 |
3.227400E-01 |
| Normal-vs-Grade 3 |
5.421300E-03 |
| Normal-vs-Grade 4 |
1.5384999940693E-09 |
| Grade 1-vs-Grade 2 |
2.746200E-02 |
| Grade 1-vs-Grade 3 |
6.639600E-04 |
| Grade 1-vs-Grade 4 |
2.555800E-04 |
| Grade 2-vs-Grade 3 |
1.886240E-02 |
| Grade 2-vs-Grade 4 |
1.13760001418939E-10 |
| Grade 3-vs-Grade 4 |
4.47609999998377E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.987600E-01 |
| Normal-vs-ccB subtype |
1.82716000000083E-05 |
| ccA subtype-vs-ccB subtype |
3.59050000842132E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.964300E-02 |
| Normal-vs-N1 |
6.520900E-03 |
| N0-vs-N1 |
1.404970E-01 |
|
|
